Gf Fund Management Co. Ltd. Gilead Sciences, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.51 Trillion
- Q3 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 298,547 shares of GILD stock, worth $37 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
298,547
Previous 300,002
0.48%
Holding current value
$37 Million
Previous $33.3 Billion
0.37%
% of portfolio
0.6%
Previous 0.67%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
2,367Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...